Bicycle Therapeutics PLC (BCYC)
22.58
-0.64
(-2.76%)
USD |
NASDAQ |
Nov 14, 16:00
22.54
-0.04
(-0.16%)
Pre-Market: 20:00
Bicycle Therapeutics Cash and Short Term Investments (Quarterly): 890.86M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 890.86M |
| June 30, 2024 | 961.36M |
| March 31, 2024 | 457.00M |
| December 31, 2023 | 526.42M |
| September 30, 2023 | 572.09M |
| June 30, 2023 | 340.43M |
| March 31, 2023 | 293.82M |
| December 31, 2022 | 339.15M |
| September 30, 2022 | 361.47M |
| June 30, 2022 | 372.77M |
| March 31, 2022 | 407.37M |
| December 31, 2021 | 438.68M |
| Date | Value |
|---|---|
| September 30, 2021 | 259.52M |
| June 30, 2021 | 198.74M |
| March 31, 2021 | 195.90M |
| December 31, 2020 | 135.99M |
| September 30, 2020 | 149.84M |
| June 30, 2020 | 96.91M |
| March 31, 2020 | 109.64M |
| December 31, 2019 | 92.12M |
| September 30, 2019 | 95.95M |
| June 30, 2019 | 108.54M |
| March 31, 2019 | 59.37M |
| December 31, 2018 | 63.38M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
92.12M
Minimum
Dec 2019
961.36M
Maximum
Jun 2024
360.00M
Average
339.79M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 214.79M |
| NuCana PLC | 14.72M |
| TC BioPharm (Holdings) PLC | 1.238M |
| Autolus Therapeutics PLC | 705.94M |
| Biodexa Pharmaceuticals PLC | 6.394M |